Twenty eyes of 16 diabetic patients affected by proliferative diabetic retinopathy were randomly treated with frequency-doubled Nd:YAG (532 nm) and argon-green (514 nm) lasers. Each of the two groups consisted of ten eyes. The mean follow-up period was 5.80 months (SD=1.36) in the first group and 5.70 months (SD=1.77) in the second group. Evolution of visual acuity and regression of new vessels were similar in the two treatment groups. The authors discuss the clinical results in the light of the histological data present in the literature and of data they have obtained in one human eye. On the basis of their preliminary results, the authors underline the practical advantages of the employment of the frequency-doubled Nd:YAG laser in clinical practice.
|Number of pages||6|
|Journal||Lasers and Light in Ophthalmology|
|Publication status||Published - 1991|
ASJC Scopus subject areas